Experience
Eli Lilly and Company
Actavis Elizabeth LLC
The U.S. Court of Appeals for the Federal Circuit reversed a district court’s ruling of invalidity for lack of enablement/utility of Finnegan client, Eli Lilly and Company’s method of use patent on Strattera® and upheld the court’s rulings of validity on other grounds and the judgment of infringement in a case involving numerous generic drug manufacturers. The Federal Circuit’s ruling in Lilly’s favor provides protection for Lilly’s Strattera® franchise through May 2017.
Eli Lilly and Company v. Actavis Elizabeth LLC, 10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
Eli Lilly and Company v. Actavis Elizabeth LLC, 2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk
Federal Circuit reverses ITC finding in favor of Finnegan client John Mezzalingua Associates
John Mezzalingua Associates, Inc.
Hyundai Motor Co.; Kia Motors Corp.
Sun Pharmaceutical Inds. v. Eli Lilly and Co.
Eli Lilly and Company
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Federal Circuit vacates IPR rulings in two appeals in favor of Finnegan client PPC Broadband
PPC Broadband
Eli Lilly and Company
Federal Circuit rules in favor of Finnegan client in radial arm saw guard patent case
Michael S. Powell
District court enters judgment of noninfringement for Finnegan client Philips
Koninklijke Philips Electronics N.V.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.